Boston Scientific Corporation BSX

43.92 (0.76) (1.70%) as of 25 Sep
Market cap
$64.7B
P/E
17.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Boston Scientific Corporation (BSX) P/E ratio

As of 25 September 2026, Boston Scientific Corporation (BSX) trades at a P/E ratio of 17.7×. Over the past ten years it has ranged from 0.0× (March 2021) to 442× (April 2021); the current reading is higher than 20% of that period. That is below the Medical Devices industry median of 22.2× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 48.6× (31.37%)
FY2024 70.9× 31.14%
FY2023 54.1× (47.13%)
FY2022 102× 66.07%
FY2021 61.6× —
FY2020 0.0× —
FY2019 13.4× (54.19%)
FY2018 29.2× (90.76%)
FY2017 316× 275.50%
FY2016 84.2× —

Quarterly

Period P/E ratio Change
Jun 2026 17.2× (34.18%)
Mar 2026 26.1× (46.26%)
Dec 2025 48.6× (5.82%)
Sep 2025 51.7× (18.24%)
42 more quarters

Against its own ten years

Low 0.0× High 442×
Ten-year median 62.7×
Current reading's percentile 20

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 15.3×
BSX Boston Scientific Corporation 17.7×
PHG Koninklijke Philips N.V. compare 18.2×
MDT Medtronic PLC compare 21.7×
STE STERIS plc compare 25.4×
SYK Stryker Corporation compare 28.0×
ABT Abbott Laboratories compare 32.8×
DXCM DexCom, Inc. compare 33.4×
EW Edwards Lifesciences Corporation compare 49.6×
Medical Devices industry median 22.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BSX